112 related articles for article (PubMed ID: 18481983)
21. The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function.
Sultana MA; Cluning C; Kwong WS; Polain N; Pavlos NJ; Ratajczak T; Walsh JP; Xu J; Rea SL
PLoS One; 2021; 16(11):e0259556. PubMed ID: 34735553
[TBL] [Abstract][Full Text] [Related]
22. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
Johnson-Pais TL; Wisdom JH; Weldon KS; Cody JD; Hansen MF; Singer FR; Leach RJ
J Bone Miner Res; 2003 Oct; 18(10):1748-53. PubMed ID: 14584883
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional studies of mutations affecting the UBA domain of SQSTM1 (p62) which cause Paget's disease of bone.
Layfield R; Ciani B; Ralston SH; Hocking LJ; Sheppard PW; Searle MS; Cavey JR
Biochem Soc Trans; 2004 Nov; 32(Pt 5):728-30. PubMed ID: 15493999
[TBL] [Abstract][Full Text] [Related]
24. Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.
Collet C; Michou L; Audran M; Chasseigneaux S; Hilliquin P; Bardin T; Lemaire I; Cornélis F; Launay JM; Orcel P; Laplanche JL
J Bone Miner Res; 2007 Feb; 22(2):310-7. PubMed ID: 17129171
[TBL] [Abstract][Full Text] [Related]
25. Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.
Hocking LJ; Mellis DJ; McCabe PS; Helfrich MH; Rogers MJ
Biochem Biophys Res Commun; 2010 Nov; 402(3):543-8. PubMed ID: 20971078
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and morphological detection of inclusion bodies in autophagy-deficient mice.
Waguri S; Komatsu M
Methods Enzymol; 2009; 453():181-96. PubMed ID: 19216907
[TBL] [Abstract][Full Text] [Related]
27. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease.
Salminen A; Kaarniranta K; Haapasalo A; Hiltunen M; Soininen H; Alafuzoff I
Prog Neurobiol; 2012 Jan; 96(1):87-95. PubMed ID: 22138392
[TBL] [Abstract][Full Text] [Related]
28. Mutant p62/SQSTM1 UBA domains linked to Paget's disease of bone differ in their abilities to function as stabilization signals.
Heinen C; Garner TP; Long J; Böttcher C; Ralston SH; Cavey JR; Searle MS; Layfield R; Dantuma NP
FEBS Lett; 2010 Apr; 584(8):1585-90. PubMed ID: 20230821
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin.
Isogai S; Morimoto D; Arita K; Unzai S; Tenno T; Hasegawa J; Sou YS; Komatsu M; Tanaka K; Shirakawa M; Tochio H
J Biol Chem; 2011 Sep; 286(36):31864-74. PubMed ID: 21715324
[TBL] [Abstract][Full Text] [Related]
30. Application of ubiquitin immunohistochemistry to the diagnosis of disease.
Lowe J; Hand N; Mayer RJ
Methods Enzymol; 2005; 399():86-119. PubMed ID: 16338351
[TBL] [Abstract][Full Text] [Related]
31. The adaptor protein p62/SQSTM1 in osteoclast signaling pathways.
McManus S; Roux S
J Mol Signal; 2012 Jan; 7():1. PubMed ID: 22216904
[TBL] [Abstract][Full Text] [Related]
32. Roles of VCP in human neurodegenerative disorders.
Kakizuka A
Biochem Soc Trans; 2008 Feb; 36(Pt 1):105-8. PubMed ID: 18208395
[TBL] [Abstract][Full Text] [Related]
33. Signal integration and diversification through the p62 scaffold protein.
Moscat J; Diaz-Meco MT; Wooten MW
Trends Biochem Sci; 2007 Feb; 32(2):95-100. PubMed ID: 17174552
[TBL] [Abstract][Full Text] [Related]
34. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone.
Morissette J; Laurin N; Brown JP
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P38-44. PubMed ID: 17229007
[TBL] [Abstract][Full Text] [Related]
35. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
36. Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone.
Cavey JR; Ralston SH; Sheppard PW; Ciani B; Gallagher TR; Long JE; Searle MS; Layfield R
Calcif Tissue Int; 2006 May; 78(5):271-7. PubMed ID: 16691492
[TBL] [Abstract][Full Text] [Related]
37. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity.
Wang Z; Figueiredo-Pereira ME
Mol Cell Neurosci; 2005 Jun; 29(2):222-31. PubMed ID: 15911346
[TBL] [Abstract][Full Text] [Related]
39. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
Paul S
Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
[TBL] [Abstract][Full Text] [Related]
40. Identification and molecular characterization of a novel splice-site mutation (G1205C) in the SQSTM1 gene causing Paget's disease of bone in an extended American family.
Beyens G; Wuyts W; Cleiren E; de Freitas F; Tiegs R; Van Hul W
Calcif Tissue Int; 2006 Nov; 79(5):281-8. PubMed ID: 17120186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
